Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.
Watanabe K, Kimura S, Seki M, Isobe T, Kubota Y, Sekiguchi M, Sato-Otsubo A, Hiwatari M, Kato M, Oka A, Koh K, Sato Y, Tanaka H, Miyano S, Kawai T, Hata K, Ueno H, Nannya Y, Suzuki H, Yoshida K, Fujii Y, Nagae G, Aburatani H, Ogawa S, Takita J.
Watanabe K, et al. Among authors: sato otsubo a, sato y.
Oncogene. 2022 Nov;41(46):4994-5007. doi: 10.1038/s41388-022-02489-2. Epub 2022 Nov 1.
Oncogene. 2022.
PMID: 36319669
Free PMC article.